[Fungal infections in patients undergoing solid organ transplantation].
Muñoz
P
P
Servicio de Microbiología Clínica-Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid. pmunoz@micro.hggm.es
Bouza
E
E
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology; D002177:Candidiasis / Q000150:complications; D002445:Celiac Artery; D003586:Cytomegalovirus Infections / Q000209:etiology; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015994:Incidence; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000209:etiology; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology; D013997:Time Factors; D014180:Transplantation / Q000009:adverse effects; D014230:Triazoles / Q000627:therapeutic use
D000935:Antifungal Agents; D014230:Triazoles; D000666:Amphotericin B